MCC
UBX

Money Concepts Capital’s Unity Biotechnology UBX Stock Holding History

Money Concepts Capital’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-60
Closed -$164 – 2724
2022
Q4 		$164 Buy
+60
New +$174 ﹤0.01% 3115
2022
Q2 		– Sell
-10
Closed – – 2547
2022
Q1 		$0 Buy
+10
New +$112 ﹤0.01% 2776

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Money Concepts Capital's UBX Position: Q1 2023 in Review

Money Concepts Capital sold out of Unity Biotechnology (UBX) in Q1 2023, closing a stake of 60 shares — an estimated $164 sold.

Money Concepts Capital first reported a position in UBX in Q1 2022 and held it in 2 quarters. The position peaked at $164 in Q4 2022. 46 funds tracked by Wall St. Rank hold UBX as of Q1 2023.

  • Money Concepts Capital reported no remaining Unity Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 60 Unity Biotechnology shares in Q1 2023, an estimated $164.
  • Money Concepts Capital first reported a position in Unity Biotechnology in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Unity Biotechnology position peaked at $164 in Q4 2022.
  • 46 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.